Tejara Capital LTD Trevi Therapeutics, Inc. Transaction History
Tejara Capital LTD
- $272 Billion
- Q1 2024
A detailed history of Tejara Capital LTD transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 37,481 shares of TRVI stock, worth $96,700. This represents 0.05% of its overall portfolio holdings.
Number of Shares
37,481
Previous 1,269,000
97.05%
Holding current value
$96,700
Previous $1.7 Billion
92.4%
% of portfolio
0.05%
Previous 0.71%
Shares
5 transactions
Others Institutions Holding TRVI
# of Institutions
79Shares Held
50.5MCall Options Held
2.2KPut Options Held
600-
Nea Management Company, LLC Timonium, MD11.4MShares$29.3 Million2.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$19 Million1.34% of portfolio
-
Rubric Capital Management LP New York, NY5.56MShares$14.4 Million0.65% of portfolio
-
Viking Global Investors LP4.4MShares$11.4 Million0.06% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$8.83 Million1.01% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $150M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...